학술논문
Outpatient Treatment with AZD7442 (Tixagevimab/Cilgavimab) Prevented COVID-19 Hospitalizations over 6 Months and Reduced Symptom Progression in the TACKLE Randomized Trial
Document Type
Article
Author
Source
In: Infectious Diseases and Therapy . (Infectious Diseases and Therapy, September 2023, 12(9):2269-2287)
Subject
Language
English
ISSN
21936382
21938229
21938229